Related references
Note: Only part of the references are listed.Increased Ga-68-DOTATATE Uptake in PET Imaging Discriminates Meningioma and Tumor-Free Tissue
Walter Rachinger et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Somatostatin Receptor-Targeted Radiopeptide Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial
Nicolas Marincek et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States
Varun R. Kshettry et al.
NEURO-ONCOLOGY (2015)
Uptake and tracer kinetics of O-(2-18F-fluoroethyl)-L-tyrosine in meningiomas: preliminary results
Jan F. Cornelius et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Comparison of 68Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results
Ali Afshar-Oromieh et al.
NEURO-ONCOLOGY (2015)
Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma
Andrew D. Norden et al.
NEUROLOGY (2015)
Detection of cranial meningiomas: comparison of 68Ga-DOTATOC PET/CT and contrast-enhanced MRI
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Clinical characteristics of meningiomas assessed by 11C-methionine and 18F-fluorodeoxyglucose positron-emission tomography
Hideyuki Arita et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Prediction of high-grade meningioma by preoperative MRI assessment
Yosuke Kawahara et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Positron Emission Tomography Imaging of Meningioma in Clinical Practice: Review of Literature and Future Directions
Jan Frederick Cornelius et al.
NEUROSURGERY (2012)
SIMULTANEOUS 68GA-DOTATOC-PET/MRI FOR IMRT TREATMENT PLANNING FOR MENINGIOMA: FIRST EXPERIENCE
Daniela Thorwarth et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma
Derek R. Johnson et al.
NEURO-ONCOLOGY (2011)
Predicting postoperative hydrocephalus in 227 patients with skull base meningioma
Jan-Karl Burkhardt et al.
NEUROSURGICAL FOCUS (2011)
Multiple meningioma with different grades of malignancy: Case report with genetic analysis applying single-nucleotide polymorphism array and classical cytogenetics
Kristin Mocker et al.
PATHOLOGY RESEARCH AND PRACTICE (2011)
Intracranial meningiomas of atypical (WHO grade II) histology
Leland Rogers et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Modern meningioma imaging techniques
D. Saloner et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Overexpression of SSTR2 inhibited the growth of SSTR2-positive tumors via multiple signaling pathways
Tianhong Zhou et al.
ACTA ONCOLOGICA (2009)
18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma
Jeong Won Lee et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma
Mirco Bartolomei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
[68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning
Barbara Gehler et al.
RADIATION ONCOLOGY (2009)
Histological classification and molecular genetics of meningiomas
Markus J. Riemenschneider et al.
LANCET NEUROLOGY (2006)
Epidemiology of intracranial meningioma
EB Claus et al.
NEUROSURGERY (2005)
Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity
S Arena et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Multiple meningiomas consisting of fibrous meningioma and anaplastic meningioma
T Tomita et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2003)
Share Paper
